Works by Buse, John B.
Results: 319
Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial Results.
- Published in:
- 2020
- By:
- Publication type:
- journal article
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 6, p. 558, doi. 10.1002/dmrr.999
- By:
- Publication type:
- Article
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14552
- By:
- Publication type:
- Article
Comprehensive Pulmonary Safety Review of Inhaled Technosphere<sup>®</sup> Insulin in Patients with Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 10, p. 973, doi. 10.1007/s40261-020-00958-8
- By:
- Publication type:
- Article
LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ.
- Published in:
- Diabetology & Metabolic Syndrome, 2016, v. 8, p. 1, doi. 10.1186/s13098-016-0153-5
- By:
- Publication type:
- Article
Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications.
- Published in:
- Clinical Epidemiology, 2024, v. 16, p. 379, doi. 10.2147/CLEP.S458901
- By:
- Publication type:
- Article
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 15, p. 1515, doi. 10.1001/jama.2014.3321
- By:
- Publication type:
- Article
Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.
- Published in:
- Diabetes Care, 2025, v. 48, n. 1, p. 118, doi. 10.2337/dc24-1779
- By:
- Publication type:
- Article
Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based Cohort Study From the RECOVER Program.
- Published in:
- Diabetes Care, 2024, v. 47, n. 11, p. 1930, doi. 10.2337/dca24-0032
- By:
- Publication type:
- Article
Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C).
- Published in:
- Diabetes Care, 2024, v. 47, n. 10, p. 1846, doi. 10.2337/dc24-1003
- By:
- Publication type:
- Article
Clinical Research Takes a Village: Paying Homage to the Unsung Members of the Team.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
A New Opportunity in Diabetes Care : Linking Articles to Presentations From the American Diabetes Association Scientific Sessions.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Mortality in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- Published in:
- Diabetes Care, 2024, v. 47, n. 4, p. 589, doi. 10.2337/dc23-1356
- By:
- Publication type:
- Article
Reflecting on a Year at the Helm of Diabetes Care.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
A New Partnership: Bringing Novel Aspects of CDC Data to Diabetes Care.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Felicia Hill-Briggs: A Tireless Worker for Better Outcomes and Social Justice in Diabetes.
- Published in:
- 2023
- By:
- Publication type:
- Obituary
Impact of Continuous Glucose Monitoring Initiation on Emergency Health Services Utilization.
- Published in:
- Diabetes Care, 2023, v. 46, n. 8, p. e146, doi. 10.2337/dc23-0341
- By:
- Publication type:
- Article
Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2.
- Published in:
- Diabetes Care, 2023, v. 46, n. 7, p. 1432, doi. 10.2337/dc22-2539
- By:
- Publication type:
- Article
Reducing Bias in Academic Publishing: The Diabetes Care Approach.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
The Art of Diabetes Care.
- Published in:
- Diabetes Care, 2023, v. 46, n. 2, p. 227, doi. 10.2337/dci22-0059
- By:
- Publication type:
- Article
"The Times They Are A-Changin'" at Diabetes Care.
- Published in:
- Diabetes Care, 2023, v. 46, n. 1, p. 3, doi. 10.2337/dci22-0045
- By:
- Publication type:
- Article
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2022, v. 45, n. 11, p. 2709, doi. 10.2337/dc22-0730
- By:
- Publication type:
- Article
Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort.
- Published in:
- Diabetes Care, 2022, v. 45, n. 7, p. 1512, doi. 10.2337/dc21-2659
- By:
- Publication type:
- Article
Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
COVID-19, Hyperglycemia, and New-Onset Diabetes.
- Published in:
- Diabetes Care, 2021, v. 44, n. 12, p. 2645, doi. 10.2337/dc21-1318
- By:
- Publication type:
- Article
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Further RISE'ing to the Challenge of Type 2 Diabetes in Youth.
- Published in:
- Diabetes Care, 2021, v. 44, n. 9, p. 1934, doi. 10.2337/dci21-0023
- By:
- Publication type:
- Article
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters.
- Published in:
- Diabetes Care, 2020, v. 43, n. 8, p. 1695, doi. 10.2337/dc20-1192
- By:
- Publication type:
- Article
COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487-493.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
- Published in:
- 2020
- By:
- Publication type:
- journal article
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article